Global Oncology Drugs Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 160693
- Pages: 150
-
Format:
Summary
The global Oncology Drugs market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Oral Therapy
Injectable Therapy
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis A.G
Laboratrio Cristlia
Medley Genomics
F. Hoffmann-La Roche Ltd
Icon Plc.
Sanofi S.A.
Laboratoires Pierre Fabre
Eurofarma Laboratrios S.A.
Ach Laboratrios Farmacuticos S.A.
Laboratorios IMA
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Targeted Therapy
Chemotherapy
Hormonal Therapy
Biologic Therapy
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Oncology Drugs of Research
1.1.1 Definition
1.1.2 Specifications of Oncology Drugs
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Oral Therapy Overview
1.2.1.2 Injectable Therapy Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Targeted Therapy
1.3.1.2 Chemotherapy
1.3.1.3 Hormonal Therapy
1.3.1.4 Biologic Therapy
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Oral Therapy Market Size 2018-2023
3.1.1.1 Global Oral Therapy Market Size and Growth Rate 2018-2023
3.1.1.2 Global Oral Therapy Market Size by Region 2018-2023
3.1.2 Injectable Therapy Market Size 2018-2023
3.1.2.1 Global Injectable Therapy Market Size and Growth Rate 2018-2023
3.1.2.2 Global Injectable Therapy Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Oral Therapy Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Oral Therapy Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Oral Therapy Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Injectable Therapy Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Injectable Therapy Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Injectable Therapy Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Targeted Therapy Market Size 2018-2023
4.1.1.1 Global Targeted Therapy Market Size and Growth Rate 2018-2023
4.1.1.2 Global Targeted Therapy Market Size by Region 2018-2023
4.1.2 Chemotherapy Market Size 2018-2023
4.1.2.1 Global Chemotherapy Market Size and Growth Rate 2018-2023
4.1.2.2 Global Chemotherapy Market Size by Region 2018-2023
4.1.3 Hormonal Therapy Market Size 2018-2023
4.1.3.1 Global Hormonal Therapy Market Size and Growth Rate 2018-2023
4.1.3.2 Global Hormonal Therapy Market Size by Region 2018-2023
4.1.4 Biologic Therapy Market Size 2018-2023
4.1.4.1 Global Biologic Therapy Market Size and Growth Rate 2018-2023
4.1.4.2 Global Biologic Therapy Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Targeted Therapy Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Targeted Therapy Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Targeted Therapy Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Chemotherapy Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Chemotherapy Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Chemotherapy Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Hormonal Therapy Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Hormonal Therapy Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Hormonal Therapy Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Biologic Therapy Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Biologic Therapy Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Biologic Therapy Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Oncology Drugs Market Competition
7.1.1 Global Oncology Drugs Market by Companies
7.1.2 Global Oncology Drugs Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Novartis A.G
8.1.1 Novartis A.G Company Profile
8.1.2 Novartis A.G Product Portfolio
8.1.3 Novartis A.G Business Performance
8.1.4 Novartis A.G Development Overview
8.2 Laboratrio Cristlia
8.2.1 Laboratrio Cristlia Company Profile
8.2.2 Laboratrio Cristlia Product Portfolio
8.2.3 Laboratrio Cristlia Business Performance
8.2.4 Laboratrio Cristlia Development Overview
8.3 Medley Genomics
8.3.1 Medley Genomics Company Profile
8.3.2 Medley Genomics Product Portfolio
8.3.3 Medley Genomics Business Performance
8.3.4 Medley Genomics Development Overview
8.4 F. Hoffmann-La Roche Ltd
8.4.1 F. Hoffmann-La Roche Ltd Company Profile
8.4.2 F. Hoffmann-La Roche Ltd Product Portfolio
8.4.3 F. Hoffmann-La Roche Ltd Business Performance
8.4.4 F. Hoffmann-La Roche Ltd Development Overview
8.5 Icon Plc.
8.5.1 Icon Plc. Company Profile
8.5.2 Icon Plc. Product Portfolio
8.5.3 Icon Plc. Business Performance
8.5.4 Icon Plc. Development Overview
8.6 Sanofi S.A.
8.6.1 Sanofi S.A. Company Profile
8.6.2 Sanofi S.A. Product Portfolio
8.6.3 Sanofi S.A. Business Performance
8.6.4 Sanofi S.A. Development Overview
8.7 Laboratoires Pierre Fabre
8.7.1 Laboratoires Pierre Fabre Company Profile
8.7.2 Laboratoires Pierre Fabre Product Portfolio
8.7.3 Laboratoires Pierre Fabre Business Performance
8.7.4 Laboratoires Pierre Fabre Development Overview
8.8 Eurofarma Laboratrios S.A.
8.8.1 Eurofarma Laboratrios S.A. Company Profile
8.8.2 Eurofarma Laboratrios S.A. Product Portfolio
8.8.3 Eurofarma Laboratrios S.A. Business Performance
8.8.4 Eurofarma Laboratrios S.A. Development Overview
8.9 Ach Laboratrios Farmacuticos S.A.
8.9.1 Ach Laboratrios Farmacuticos S.A. Company Profile
8.9.2 Ach Laboratrios Farmacuticos S.A. Product Portfolio
8.9.3 Ach Laboratrios Farmacuticos S.A. Business Performance
8.9.4 Ach Laboratrios Farmacuticos S.A. Development Overview
8.10 Laboratorios IMA
8.10.1 Laboratorios IMA Company Profile
8.10.2 Laboratorios IMA Product Portfolio
8.10.3 Laboratorios IMA Business Performance
8.10.4 Laboratorios IMA Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
